GSI Technology (GSIT) 10-Q 11 Feb 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Dec. 31, 2013	Jan. 31, 2014
Document And Entity Information	'	'
Entity Registrant Name	'GSI TECHNOLOGY INC	'
Entity Central Index Key	'0001126741	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--03-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	27,514,019
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

CONSOLIDATED_BALANCE_SHEETS_Un

CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
ASSETS.	'	'
Cash and cash equivalents	$42,040	$41,120
Short-term investments	32,779	26,139
Accounts receivable, net	9,054	10,241
Inventories	9,221	13,809
Prepaid expenses and other current assets	4,090	4,945
Deferred income taxes	1,339	1,224
Total current assets	98,523	97,478
Property and equipment, net	9,625	10,774
Long-term investments	34,199	35,495
Other assets	2,387	2,098
Total assets	144,734	145,845
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	3,015	3,804
Accrued expenses and other liabilities	3,960	3,978
Deferred revenue	2,391	3,077
Total current liabilities	9,366	10,859
Income taxes payable	1,908	2,803
Total liabilities	11,274	13,662
Commitments and contingencies (Note 6)	'	'
Stockholders' equity:	'	'
Preferred stock: $0.001 par value authorized: 5,000,000 shares; issued and outstanding: none	0	0
Common Stock: $0.001 par value authorized: 150,000,000 shares; issued and outstanding: 27,521,248 and 27,065,209 shares, respectively	28	27
Additional paid-in capital	56,092	54,004
Accumulated other comprehensive income	22	45
Retained earnings	77,318	78,107
Total stockholders' equity	133,460	132,183
Total liabilities and stockholders' equity	$144,734	$145,845

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Stockholders' Equity	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	27,521,248	27,065,209
Common stock, shares outstanding	27,521,248	27,065,209

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement	'	'	'	'
Net revenues	$13,778	$17,514	$45,732	$50,307
Cost of revenues	8,410	10,170	25,496	28,994
Gross profit	5,368	7,344	20,236	21,313
Operating expenses:	'	'	'	'
Research and development	2,780	2,858	8,728	8,568
Selling, general and administrative	4,490	3,891	13,710	9,764
Total operating expenses	7,270	6,749	22,438	18,332
Income (loss) from operations	-1,902	595	-2,202	2,981
Interest income, net	92	117	291	348
Other income (expense), net	-30	-8	-33	28
Income (loss) before income taxes	-1,840	704	-1,944	3,357
Provision (benefit) for income taxes	-1,106	-140	-1,155	461
Net income (loss)	($734)	$844	($789)	$2,896
Net income (loss) per share:	'	'	'	'
Basic	($0.03)	$0.03	($0.03)	$0.11
Diluted	($0.03)	$0.03	($0.03)	$0.10
Weighted average shares used in per share calculations:	'	'	'	'
Basic	27,667	26,963	27,495	27,152
Diluted	27,667	27,987	27,495	27,957

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Consolidated Statements Of Comprehensive Income	'	'	'	'
Net income (loss)	($734)	$844	($789)	$2,896
Net unrealized gain (loss) on available-for-sale investments, net of tax	15	-38	-23	-46
Comprehensive net income (loss)	($719)	$806	($812)	$2,850

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net income (loss)	($789,000)	$2,896,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'
Allowance for sales returns, doubtful accounts and other	-15,000	0
Provision for excess and obsolete inventories	1,642,000	544,000
Depreciation and amortization	1,486,000	1,847,000
Stock-based compensation	1,644,000	1,688,000
Deferred income taxes	-115,000	63,000
Windfall tax benefits from stock options exercised	-280,000	-20,000
Amortization of bond premium on investments	640,000	792,000
Changes in assets and liabilities:	'	'
Accounts receivable	1,202,000	1,917,000
Inventory	2,946,000	993,000
Prepaid expenses and other assets	439,000	941,000
Accounts payable	-789,000	-1,730,000
Accrued expenses and other liabilities	-582,000	-516,000
Deferred revenue	-686,000	-201,000
Net cash provided by operating activities	6,743,000	9,214,000
Cash flows from investing activities:	'	'
Purchase of investments	-29,927,000	-27,660,000
Sales and maturities of short-term investments	23,912,000	22,673,000
Purchases of property and equipment	-253,000	-313,000
Net cash used in investing activities	-6,268,000	-5,300,000
Cash flows from financing activities:	'	'
Repurchase of common stock	-2,536,000	-3,626,000
Windfall tax benefits from stock options exercised	280,000	20,000
Proceeds from issuance of common stock under employee stock plans	2,701,000	654,000
Net cash provided by (used in) financing activities	445,000	-2,952,000
Net increase in cash and cash equivalents	920,000	962,000
Cash and cash equivalents at beginning of the period	41,120,000	31,634,000
Cash and cash equivalents at end of the period	42,040,000	32,596,000
Non-cash investing activities:	'	'
Purchases of property and equipment through accounts payable and accruals	0	91,000
Supplemental cash flow information:	'	'
Net cash paid for income taxes	$28,000	$359,000

1_THE_COMPANY_AND_SUMMARY_OF_S

1. THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Dec. 31, 2013
Accounting Policies	'
NOTE 1-THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1—THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of presentation
	The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission.  Accordingly, the interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein.  The Company believes that the disclosures are adequate to make the information not misleading.  However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2013.
	The consolidated results of operations for the three months and nine months ended December 31, 2013 are not necessarily indicative of the results to be expected for the entire fiscal year.
	Significant accounting policies
	The Company’s significant accounting policies are disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2013.
	Litigation and settlement costs
	From time to time, the Company is involved in legal actions. The Company currently is a party to pending legal proceedings which it is defending aggressively.  See Note 6 for additional information regarding this pending litigation.  There are many uncertainties associated with any litigation, and the Company may not prevail.  The litigation, regardless of its eventual outcome, will be costly and time consuming and, should the outcome be adverse to the Company, could result in the Company being required to pay significant monetary damages.  If that occurs, our business, financial condition and results of operations could be materially and adversely affected. If information becomes available that causes us to determine that a loss in any of our pending litigation, or the settlement of such litigation, is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with GAAP. However, the actual liability in any such litigation may be materially different from our estimates, which could require us to record additional costs.
	Excess and Obsolete Inventory Write-Down
	The Company recorded write-downs of excess and obsolete inventories of $1.1 million and $253,000, respectively, for the three months ended December 31, 2013 and 2012 and $1.6 million and $544,000, respectively, for the nine months ended December 31, 2013 and 2012. The increased write-downs recorded in the three and nine months ended December 31, 2013 were taken in response to the decline in the business and in response to the fact that management’s prior expectations regarding the recoverability of certain products, which were based on estimates of increasing demand for these products in anticipation of, and following the favorable ITC ruling on June 7, 2013 and the exit of a competitor from the SRAM market in the December 2012 quarter, did not materialize.

2_NET_INCOME_LOSS_PER_COMMON_S

2. NET INCOME (LOSS) PER COMMON SHARE	9 Months Ended
	Dec. 31, 2013
Net income (loss) per share:	'
NOTE 2 - NET INCOME (LOSS) PER COMMON SHARE	'
	NOTE 2—NET INCOME (LOSS) PER COMMON SHARE
	The Company uses the treasury stock method to calculate the weighted average shares used in computing diluted net income per share. The following table sets forth the computation of basic and diluted net income (loss) per share:
		Three Months Ended Dec. 31,					Nine Months Ended Dec. 31,
		2013			2012		2013			2012
		(In thousands, except per share amounts)
	Net income (loss)	$	(734	)	$	844	$	(789	)	$	2,896
	Denominators:
	Weighted average shares—Basic	27,667			26,963		27,495			27,152
	Dilutive effect of employee stock options	—			1,024		—			805
	Dilutive effect of employee stock purchase plan options	—			—		—			—
	Weighted average shares—Dilutive	27,667			27,987		27,495			27,957
	Net income (loss) per common share—Basic	$	(0.03	)	$	0.03	$	(0.03	)	$	0.11
	Net income (loss) per common share—Diluted	$	(0.03	)	$	0.03	$	(0.03	)	$	0.1
	The following shares of common stock underlying outstanding stock options, determined on a weighted average basis, were excluded from the computation of diluted net income per share as they had an anti-dilutive effect:
		Three Months Ended Dec. 31,				Nine Months Ended Dec. 31,
		2013		2012		2013	2012
		(In thousands)
	Shares underlying options	3,027		3,243		3,026	3,130

3_BALANCE_SHEET_DETAIL

3. BALANCE SHEET DETAIL	9 Months Ended
	Dec. 31, 2013
Balance Sheet Related Disclosures	'
NOTE 3 - BALANCE SHEET DETAIL	'
	NOTE 3—BALANCE SHEET DETAIL
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Inventories:
	Work-in-progress	$	2,674		$	4,236
	Finished goods	6,002			8,772
	Inventory at distributors	545			801
		$	9,221		$	13,809
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Accounts receivable, net:
	Accounts receivable	$	9,155		$	10,357
	Less: Allowances for sales returns, doubtful accounts and other	(101		)	(116		)
		$	9,054		$	10,241
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Prepaid expenses and other current assets:
	Prepaid tooling and masks	$	580		$	1,230
	Prepaid income taxes	2,144			2,037
	Other receivables	388			557
	Other prepaid expenses	978			1,121
		$	4,090		$	4,945
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Property and equipment, net:
	Computer and other equipment	$	16,483		$	16,344
	Software	4,779			4,690
	Land	3,900			3,900
	Building and building improvements	2,256			2,256
	Furniture and fixtures	110			110
	Leasehold improvements	792			767
	Construction in progress	—			51
		28,320			28,118
	Less: Accumulated depreciation and amortization	(18,695		)	(17,344		)
		$	9,625		$	10,774
	Depreciation and amortization expense was $443,000 and $531,000, respectively, for the three months ended December 31, 2013 and 2012 and $1,351,000 and $1,712,000, respectively, for the nine months ended December 31, 2013 and 2012.
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Other Assets:
	Non-current deferred income taxes	$	1,696		$	1,272
	Intangibles, net	609			744
	Deposits	82			82
		$	2,387		$	2,098
	The following table summarizes the components of intangible assets and related accumulated amortization balances at December 31, 2013 (in thousands):
		Gross
		Carrying			Accumulated			Net Carrying
		Amount			Amortization			Amount
	Intangible assets:
	Product designs	$	590		$	(365	)	$	225
	Patents	720			(347		)	373
	Software	80			(69		)	11
	Total	$	1,390		$	(781	)	$	609
	Amortization of intangible assets included in cost of revenues was $45,000 and $45,000, respectively, for the three months ended December 31, 2013 and 2012 and $135,000 and $135,000, respectively, for the nine months ended December 31, 2013 and 2012.
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Accrued expenses and other liabilities:
	Accrued compensation	$	2,238		$	2,181
	Accrued professional fees	701			560
	Accrued commissions	299			353
	Other accrued expenses	722			884
		$	3,960		$	3,978

4_INCOME_TAXES

4. INCOME TAXES	9 Months Ended
	Dec. 31, 2013
Income Tax Disclosure	'
NOTE 4-INCOME TAXES	'
	NOTE 4—INCOME TAXES
	The current portion of the Company’s unrecognized tax benefits was $0 at both December 31, 2013 and March 31, 2013. The long-term portion at December 31, 2013 and March 31, 2013 was $2,163,000 and $2,803,000, respectively, of which the timing of the resolution is uncertain.  As of December 31, 2013, $544,000 of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets.  The unrecognized tax benefit balance of $2,329,000 as of December 31, 2013 would affect the Company’s effective tax rate if recognized.  It is possible, however, that some months or years may elapse before an uncertain position for which the Company has established a reserve is resolved.
	Management believes that it is reasonably possible that within the next twelve months the Company could have a reduction in uncertain tax benefits of up to $775,000, including interest and penalties, related to positions taken with respect to credits and loss carryforwards on previously filed tax returns.
	The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes in the Condensed Consolidated Statements of Operations.
	The Company is subject to taxation in the United States and various state and foreign jurisdictions.  Fiscal years 2010 through 2013 remain open to examination by federal tax authorities, and fiscal years 2009 through 2013 remain open to examination by California tax authorities.  In the three months ended June 30, 2012, the Company settled an examination by the California Franchise Tax Board.  The tax provision for the nine month period ended December 31, 2012 includes a discrete benefit of $168,000 associated with the net result of the settlement and the associated tax reserves, including interest to date. During the quarter ended December 31, 2013, the Company established a valuation allowance of $371,000 for California research and development tax credit carryovers that are not expected to be utilized in future years.
	The Company’s estimated annual effective income tax rate was approximately 34.5% and 26.1% as of December 31, 2013 and 2012, respectively.  The differences between the effective income tax rate and the applicable statutory U.S. income tax rate in each period were primarily due to the effects of tax credits, foreign tax rate differentials and tax free interest income, offset by stock-based compensation expense.

5_FINANCIAL_INSTRUMENTS

5. FINANCIAL INSTRUMENTS	9 Months Ended
	Dec. 31, 2013
Investments, All Other Investments	'
NOTE 5-FINANCIAL INSTRUMENTS	'
	NOTE 5—FINANCIAL INSTRUMENTS
	Fair value measurements
	Authoritative accounting guidance for fair value measurements provides a framework for measuring fair value and related disclosure.  The guidance applies to all financial assets and financial liabilities that are measured on a recurring basis.  The guidance requires fair value measurement to be classified and disclosed in one of the following three categories:
	Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities.  The fair value of available-for-sale securities included in the Level 1 category is based on quoted prices that are readily and regularly available in an active market.  As of December 31, 2013, the Level 1 category included money market funds of $7.0 million, which were included in cash and cash equivalents in the Condensed Consolidated Balance Sheet.
	Level 2: Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets at the measurement date; quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly. The fair value of available-for-sale securities included in the Level 2 category is based on the market values obtained from an independent pricing service that were evaluated using pricing models that vary by asset class and may incorporate available trade, bid and other market information and price quotes from well established independent pricing vendors and broker-dealers. As of December 31, 2013, the Level 2 category included short-term investments of $32.8 million and long-term investments of $34.2 million, which were comprised of certificates of deposit, corporate debt securities and government and agency securities.
	Level 3: Valuations based on inputs that are unobservable and involve management judgment and the reporting entity’s own assumptions about market participants and pricing.  As of December 31, 2013, the Company had no Level 3 financial assets measured at fair value in the Condensed Consolidated Balance Sheet.
	The fair value of financial assets and liabilities measured on a recurring basis is as follows (in thousands):
				Fair Value Measurements at Reporting Date Using
				Quoted Prices
				in Active		Significant
				Markets for		Other			Significant
				Identical Assets		Observable			Unobservable
				and Liabilties		Inputs			Inputs
		Dec. 31, 2013		(Level 1)		(Level 2)			(Level 3)
	Assets:
	Money market funds	$	7,044	$	7,044	$	—		$	—
	Marketable securities	66,978		—		66,978			—
	Total	$	74,022	$	7,044	$	66,978		$	—
				Fair Value Measurements at Reporting Date Using
				Quoted Prices
				in Active		Significant
				Markets for		Other			Significant
				Identical Assets		Observable			Unobservable
				and Liabilties		Inputs			Inputs
		March 31, 2013		(Level 1)		(Level 2)			(Level 3)
	Assets:
	Money market funds	$	10,445	$	10,445	$	—		$	—
	Marketable securities	61,634		—		61,634			—
	Total	$	72,079	$	10,445	$	61,634		$	—
	Short-term and long-term investments
	All of the Company’s short-term and long-term investments are classified as available-for-sale.  Available-for-sale debt securities with maturities greater than twelve months are classified as long-term investments when they are not intended for use in current operations.  Investments in available-for-sale securities are reported at fair value with unrecognized gains (losses), net of tax, as a component of accumulated other comprehensive income in the Condensed Consolidated Balance Sheets.  The Company had money market funds of $7.0 million and $10.4 million at December 31, 2013 and March 31, 2013, respectively, included in cash and cash equivalents in the Condensed Consolidated Balance Sheet.  The Company monitors its investments for impairment periodically and records appropriate reductions in carrying values when declines are determined to be other-than-temporary.
	The following table summarizes the Company’s available-for-sale investments:
		Dec. 31, 2013
				Gross		Gross
				Unrealized		Unrealized			Fair
		Cost		Gains		Losses			Value
		(In thousands)
	Short-term investments:
	State and municipal obligations	$	7,688	$	1				$	7,689
	Corporate notes	3,018		7					3,025
	Agency bonds	5,527		8					5,535
	Certificates of deposit	14,999		5		—			15,004
	Other	1,524		2					1,526
	Total short-term investments	$	32,756	$	23	$	—		$	32,779
	Long-term investments:
	State and municipal obligations	$	9,048	$	2	$	—		$	9,050
	Corporate notes	7,408		27		—			7,435
	Agency bonds	999		—		(2		)	997
	Certificates of deposit	10,751		—		(21		)	10,730
	Other	5,988		—		(1		)	5,987
	Total long-term investments	$	34,194	$	29	$	(24	)	$	34,199
		March 31, 2013
				Gross		Gross
				Unrealized		Unrealized			Fair
		Cost		Gains		Losses			Value
		(In thousands)
	Short-term investments:
	State and municipal obligations	$	10,564	$	17	$	—		$	10,581
	Corporate notes	6,052		14		—			6,066
	Certificates of deposit	9,480		12		—			9,492
	Total short-term investments	$	26,096	$	43	$	—		$	26,139
	Long-term investments:
	State and municipal obligations	$	11,992	$	3	$	—		$	11,995
Corporate notes	8,436		14		—			8,450
Certificates of deposit	9,008		18		—			9,026
Other	6,042		—		(18		)	6,024
Total long-term investments	$	35,478	$	35	$	(18	)	$	35,495
The Company’s investment portfolio consists of both corporate and governmental securities that have a maximum maturity of three years. All unrealized gains are due to changes in interest rates and bond yields.  Subject to normal credit risks, the Company has the ability to realize the full value of all these investments upon maturity.
The deferred tax liability related to unrecognized gains and losses on short-term and long-term investments was $7,000 and $14,000 at December 31, 2013 and March 31, 2013, respectively.
As of December 31, 2013, contractual maturities of the Company’s available-for-sale non-equity investments were as follows:
			Fair
	Cost		Value
	(In thousands)
Maturing within one year	$	32,756	$	32,779
Maturing in one to three years	34,194		34,199
Maturing in more than three years	—		—
	$	66,950	$	66,978
The Company classifies its short-term investments as “available-for-sale” as they are intended to be available for use in current operations.

6_COMMITMENTS_AND_CONTINGENCIE

6. COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure	'
NOTE 6-COMMITMENTS AND CONTINGENCIES	'
	NOTE 6—COMMITMENTS AND CONTINGENCIES
	Indemnification obligations
	The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify the other party with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold and certain intellectual property rights. In each of these circumstances, the Company’s indemnification obligations are conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party’s claims. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements.
	It is not possible to predict the maximum potential amount of future payments that may be required under these or similar agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material effect on its business, financial condition, cash flows or results of operations.
	Product warranties
	The Company warrants its products to be free of defects generally for a period of three years. The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues. Warranty costs were not significant for the three months or nine months ended December 31, 2013 or 2012.
	Legal proceedings
	In March 2011, Cypress Semiconductor Corporation, a semiconductor manufacturer, filed a lawsuit against the Company in the United States District Court for the District of Minnesota alleging that the Company’s products, including its SigmaDDR and SigmaQuad families of Very Fast SRAMs, infringe five patents held by Cypress.  The complaint seeks unspecified damages for past infringement and a permanent injunction against future infringement.
	On June 10, 2011, Cypress filed a complaint against the Company with the United States International Trade Commission (the “ITC”).  The ITC complaint, as subsequently amended, alleged infringement by the Company of three of the five patents involved in the District Court case and one additional patent and also alleged infringement by three of our distributors and 11 of our customers who allegedly incorporate our SRAMs in their products.  The ITC complaint sought a limited exclusion order excluding the allegedly infringing SRAMs, and products containing them, from entry into the United States and permanent orders directing the Company and the other respondents to cease and desist from selling or distributing such products in the United States.  On July 21, 2011, the ITC formally instituted an investigation in response to Cypress’s complaint.   On June 7, 2013, the ITC announced that the full Commission had affirmed the determination of Chief Administrative Judge Charles E. Bullock that GSI’s SRAM devices, and products containing them, do not infringe the Cypress patents and that Cypress had failed to establish existence of a domestic industry that practices the patents.  Moreover, the Commission reversed a portion of Judge Bullock’s determination with respect to the validity of the patents, finding the asserted claims of one of the patents to have been anticipated by prior art and, therefore, invalid.  The Commission ordered the investigation terminated, and Cypress did not appeal the ruling.
	The Minnesota District Court case had been stayed pending the conclusion of the ITC proceeding. Following the termination of the ITC investigation, the stay was lifted.  On May 1, 2013, Cypress filed an additional lawsuit in the United States District Court for the Northern District of California alleging infringement by our products of five additional Cypress patents.  Like the Minnesota case, the complaint in the California lawsuit seeks unspecified damages for past infringement and a permanent injunction against future infringement.  The Company filed answers in both cases denying liability and asserting affirmative defenses.  On August 7, 2013, the parties stipulated that the claims in the Minnesota case with respect to three of the asserted patents would be dismissed without prejudice and that the claims with respect to the remaining two patents would be transferred to, and consolidated with, the California case.  On August 20, 2013, the Court in the California case ordered the cases consolidated.  Discovery in the case is proceeding.
	The Company believes that it has strong defenses against Cypress’ patent infringement claims and intends to continue to defend itself vigorously. However, the litigation process is inherently uncertain, and the Company may not prevail.  Patent litigation is particularly complex and can extend for a protracted period of time, which can substantially increase the cost of such litigation.  The Company has not recorded any loss contingency during fiscal 2011, fiscal 2012 or fiscal 2013 in connection with these legal proceedings as the Company cannot predict their outcome and cannot estimate the likelihood or potential dollar amount of any adverse results.  However, an unfavorable outcome in these proceedings could have a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the outcome occurs and in future periods.

7_STOCK_BASED_COMPENSATION

7. STOCK- BASED COMPENSATION	9 Months Ended
	Dec. 31, 2013
Equity	'
NOTE 7-STOCK- BASED COMPENSATION	'
	NOTE 7—STOCK-BASED COMPENSATION
	As of December 31, 2013, 5,671,955 shares of common stock were available for grant under the Company’s 2007 Equity Incentive Plan.
	The following table summarizes the Company’s stock option activities for the nine months ended December 31, 2013:
				Weighted
		Number of Shares		Average		Weighted
		Underlying		Remaining		Average
		Options		Contractual		Exercise			Intrinsic
		Outstanding		Life (Years)		Price			Value
	Balance at March 31, 2013	6,336,319				$	4.73
	Granted	678,483				6.42
	Exercised	(723,673	)			2.97			$	2,386,568
	Forfeited	(141,320	)			6.01
	Balance at December 31, 2013	6,149,809				$	5.09
	Options vested and exercisable	3,748,121		4.78		$	4.56		$	7,989,938
	Options vested and expected to vest	6,083,320		6.12		$	5.08		$	9,916,505
	The weighted average fair value per underlying share of options granted during the three months ended December 31, 2013 and 2012 was $2.78 and $2.43, respectively, and for the nine months ended December 31, 2013 and 2012 was $2.73 and $2.12, respectively.
	Options outstanding by exercise price at December 31, 2013 were as follows:
		Number of		Options Outstanding					Options Exercisable
		Shares		Weighted			Weighted Average				Weighted
		Underlying		Average			Remaining		Number		Average
		Options		Exercise			Contractual		Vested and		Exercise
	Exercise Price	Outstanding		Price			Life (Years)		Exercisable		Price
	$2.43 - 3.38	647,144		$	3.01		4.78		647,144		$	3.01
	$3.43 - 3.94	498,291		$	3.55		5.27		498,291		$	3.55
	$4.00	697,038		$	4		5.43		697,038		$	4
	$4.17 - 4.50	652,634		$	4.26		5.84		369,545		$	4.32
	$4.81 - 4.92	511,335		$	4.87		8.19		132,690		$	4.88
	$5.50	817,333		$	5.5		2.86		817,333		$	5.5
	$5.59 - 5.76	622,280		$	5.7		7.55		206,845		$	5.71
	$6.00 - 6.54	818,658		$	6.32		7.38		158,299		$	6.34
	$6.63 - 7.00	771,476		$	6.86		8.33		158,221		$	6.93
	$9.20	113,620		$	9.2		7.08		62,715		$	9.2
		6,149,809							3,748,121
	The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:
		Three Months Ended Dec. 31,						Nine Months Ended Dec. 31,
		2013			2012			2013			2012
		(In thousands)
	Cost of revenues	$	86		$	68		$	282		$	245
	Research and development	235			287			726			861
	Selling, general and administrative	195			210			636			582
	Total	$	516		$	565		$	1,644		$	1,688
	As stock-based compensation expense recognized in the Condensed Consolidated Statement of Operations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures in accordance with authoritative guidance.  The Company estimates forfeitures at the time of grant and revises the original estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
	The Company recognized related income tax benefits of $35,000 and $51,000, respectively, for the three months ended December 31, 2013 and 2012, and of $81,000 and $167,000, respectively, for the nine months ended December 31, 2013 and 2012.  Windfall tax benefits realized from exercised stock options were $280,000 and $20,000, respectively, for the nine months ended December 31, 2013 and 2012.  Compensation cost capitalized within inventory at December 31, 2013 was insignificant. As of December 31, 2013, the Company’s total unrecognized compensation cost was $4.0 million, which will be recognized over a weighted average period of 2.01 years.  The Company calculated the fair value of stock-based awards in the periods presented using the Black-Scholes option pricing model and the following weighted average assumptions:
		Three Months Ended Dec. 31,				Nine Months Ended Dec. 31,
		2013		2012		2013		2012
	Stock Option Plans:
	Risk-free interest rate	1.43%		0.69%		0.91 - 1.51%		0.67 - 0.79%
	Expected life (in years)	5		5		5		5
	Volatility	46.60%		50.20%		46.6 - 48.4%		50.2 - 52.9%
	Dividend yield	—%		—%		—%		—%
	Employee Stock Purchase Plan:
	Risk-free interest rate	0.07%		0.14%		0.07 - 0.09%		0.14 - 0.15%
	Expected life (in years)	0.5		0.5		0.5		0.5
	Volatility	32.80%		47.30%		30.4 - 32.8%		23.4 - 47.3%
	Dividend yield	—%		—%		—%		—%

8_SEGMENT_AND_GEOGRAPHIC_INFOR

8. SEGMENT AND GEOGRAPHIC INFORMATION	9 Months Ended
	Dec. 31, 2013
Segment Reporting	'
NOTE 8-SEGMENT AND GEOGRAPHIC INFORMATION	'
	NOTE 8—SEGMENT AND GEOGRAPHIC INFORMATION
	Based on its operating management and financial reporting structure, the Company has determined that it has one reportable business segment: the design, development and sale of integrated circuits.
	The following is a summary of net revenues by geographic area based on the location to which product is shipped:
		Three Months Ended Dec. 31,				Nine Months Ended Dec. 31,
		2013		2012		2013		2012
		(In thousands)
	United States	$	4,123	$	4,951	$	14,507	$	14,152
	China	3,465		2,746		9,736		11,054
	Malaysia	2,310		5,929		7,865		13,662
	Singapore	1,803		1,989		4,868		5,497
	Netherlands	768		575		4,180		1,580
	Rest of the world	1,309		1,324		4,576		4,362
		$	13,778	$	17,514	$	45,732	$	50,307
	All sales are denominated in United States dollars.

1_THE_COMPANY_AND_SUMMARY_OF_S1

1. THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Dec. 31, 2013
Accounting Policies	'
Basis of presentation	'
	Basis of presentation
	The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission.  Accordingly, the interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein.  The Company believes that the disclosures are adequate to make the information not misleading.  However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2013.
	The consolidated results of operations for the three months and nine months ended December 31, 2013 are not necessarily indicative of the results to be expected for the entire fiscal year.
Significant accounting policies	'
	Significant accounting policies
	The Company’s significant accounting policies are disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2013.
Litigation and settlement costs	'
	Litigation and settlement costs
	From time to time, the Company is involved in legal actions. The Company currently is a party to pending legal proceedings which it is defending aggressively.  See Note 6 for additional information regarding this pending litigation.  There are many uncertainties associated with any litigation, and the Company may not prevail.  The litigation, regardless of its eventual outcome, will be costly and time consuming and, should the outcome be adverse to the Company, could result in the Company being required to pay significant monetary damages.  If that occurs, our business, financial condition and results of operations could be materially and adversely affected. If information becomes available that causes us to determine that a loss in any of our pending litigation, or the settlement of such litigation, is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with GAAP. However, the actual liability in any such litigation may be materially different from our estimates, which could require us to record additional costs.
Excess and Obsolete Inventory Write-Down	'
	Excess and Obsolete Inventory Write-Down
	The Company recorded write-downs of excess and obsolete inventories of $1.1 million and $253,000, respectively, for the three months ended December 31, 2013 and 2012 and $1.6 million and $544,000, respectively, for the nine months ended December 31, 2013 and 2012. The increased write-downs recorded in the three and nine months ended December 31, 2013 were taken in response to the decline in the business and in response to the fact that management’s prior expectations regarding the recoverability of certain products, which were based on estimates of increasing demand for these products in anticipation of, and following the favorable ITC ruling on June 7, 2013 and the exit of a competitor from the SRAM market in the December 2012 quarter, did not materialize.

2_NET_INCOME_LOSS_PER_COMMON_S1

2. NET INCOME (LOSS) PER COMMON SHARE (Tables)	9 Months Ended
	Dec. 31, 2013
Net income (loss) per share:	'
Basic and diluted net income (loss) per share	'
		Three Months Ended Dec. 31,					Nine Months Ended Dec. 31,
		2013			2012		2013			2012
		(In thousands, except per share amounts)
	Net income (loss)	$	(734	)	$	844	$	(789	)	$	2,896
	Denominators:
	Weighted average shares—Basic	27,667			26,963		27,495			27,152
	Dilutive effect of employee stock options	—			1,024		—			805
	Dilutive effect of employee stock purchase plan options	—			—		—			—
	Weighted average shares—Dilutive	27,667			27,987		27,495			27,957
	Net income (loss) per common share—Basic	$	(0.03	)	$	0.03	$	(0.03	)	$	0.11
	Net income (loss) per common share—Diluted	$	(0.03	)	$	0.03	$	(0.03	)	$	0.1
Anti-dilutive shares	'
		Three Months Ended Dec. 31,				Nine Months Ended Dec. 31,
		2013		2012		2013	2012
		(In thousands)
	Shares underlying options	3,027		3,243		3,026	3,130

3_BALANCE_SHEET_DETAIL_Tables

3. BALANCE SHEET DETAIL (Tables)	9 Months Ended
	Dec. 31, 2013
Balance Sheet Detail Tables	'
Schedule of Inventories	'
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Inventories:
	Work-in-progress	$	2,674		$	4,236
	Finished goods	6,002			8,772
	Inventory at distributors	545			801
		$	9,221		$	13,809
Schedule of Accounts Receivable, Net	'
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Accounts receivable, net:
	Accounts receivable	$	9,155		$	10,357
	Less: Allowances for sales returns, doubtful accounts and other	(101		)	(116		)
		$	9,054		$	10,241
Schedule of Prepaid Expenses and Other Current Assets	'
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Prepaid expenses and other current assets:
	Prepaid tooling and masks	$	580		$	1,230
	Prepaid income taxes	2,144			2,037
	Other receivables	388			557
	Other prepaid expenses	978			1,121
		$	4,090		$	4,945
Schedule of Property and Equipment, Net	'
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Property and equipment, net:
	Computer and other equipment	$	16,483		$	16,344
	Software	4,779			4,690
	Land	3,900			3,900
	Building and building improvements	2,256			2,256
	Furniture and fixtures	110			110
	Leasehold improvements	792			767
	Construction in progress	—			51
		28,320			28,118
	Less: Accumulated depreciation and amortization	(18,695		)	(17,344		)
		$	9,625		$	10,774
Schedule of Other Assets	'
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Other Assets:
	Non-current deferred income taxes	$	1,696		$	1,272
	Intangibles, net	609			744
	Deposits	82			82
		$	2,387		$	2,098
Schedule of Intangible Assets	'
		Gross
		Carrying			Accumulated			Net Carrying
		Amount			Amortization			Amount
	Intangible assets:
	Product designs	$	590		$	(365	)	$	225
	Patents	720			(347		)	373
	Software	80			(69		)	11
	Total	$	1,390		$	(781	)	$	609
Schedule of Accrued Expenses and Other Liabilities	'
		Dec. 31, 2013			March 31, 2013
		(In thousands)
	Accrued expenses and other liabilities:
	Accrued compensation	$	2,238		$	2,181
	Accrued professional fees	701			560
	Accrued commissions	299			353
	Other accrued expenses	722			884
		$	3,960		$	3,978

5_FINANCIAL_INSTRUMENTS_Tables

5. FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Dec. 31, 2013
Financial Instruments Tables	'
Schedule of Fair value of financial assets and liabilities measured on a recurring basis	'
				Fair Value Measurements at Reporting Date Using
				Quoted Prices
				in Active		Significant
				Markets for		Other			Significant
				Identical Assets		Observable			Unobservable
				and Liabilties		Inputs			Inputs
		Dec. 31, 2013		(Level 1)		(Level 2)			(Level 3)
	Assets:
	Money market funds	$	7,044	$	7,044	$	—		$	—
	Marketable securities	66,978		—		66,978			—
	Total	$	74,022	$	7,044	$	66,978		$	—
				Fair Value Measurements at Reporting Date Using
				Quoted Prices
				in Active		Significant
				Markets for		Other			Significant
				Identical Assets		Observable			Unobservable
				and Liabilties		Inputs			Inputs
		March 31, 2013		(Level 1)		(Level 2)			(Level 3)
	Assets:
	Money market funds	$	10,445	$	10,445	$	—		$	—
	Marketable securities	61,634		—		61,634			—
	Total	$	72,079	$	10,445	$	61,634		$	—
Schedule of Available-for-sale investments	'
		Dec. 31, 2013
				Gross		Gross
				Unrealized		Unrealized			Fair
		Cost		Gains		Losses			Value
		(In thousands)
	Short-term investments:
	State and municipal obligations	$	7,688	$	1				$	7,689
	Corporate notes	3,018		7					3,025
	Agency bonds	5,527		8					5,535
	Certificates of deposit	14,999		5		—			15,004
	Other	1,524		2					1,526
	Total short-term investments	$	32,756	$	23	$	—		$	32,779
	Long-term investments:
	State and municipal obligations	$	9,048	$	2	$	—		$	9,050
	Corporate notes	7,408		27		—			7,435
	Agency bonds	999		—		(2		)	997
	Certificates of deposit	10,751		—		(21		)	10,730
	Other	5,988		—		(1		)	5,987
	Total long-term investments	$	34,194	$	29	$	(24	)	$	34,199
		March 31, 2013
				Gross		Gross
				Unrealized		Unrealized			Fair
		Cost		Gains		Losses			Value
		(In thousands)
	Short-term investments:
	State and municipal obligations	$	10,564	$	17	$	—		$	10,581
	Corporate notes	6,052		14		—			6,066
	Certificates of deposit	9,480		12		—			9,492
	Total short-term investments	$	26,096	$	43	$	—		$	26,139
	Long-term investments:
	State and municipal obligations	$	11,992	$	3	$	—		$	11,995
	Corporate notes	8,436		14		—			8,450
	Certificates of deposit	9,008		18		—			9,026
	Other	6,042		—		(18		)	6,024
	Total long-term investments	$	35,478	$	35	$	(18	)	$	35,495
Schedule of Contractual maturities of the available-for-sale non-equity investments	'
				Fair
		Cost		Value
		(In thousands)
	Maturing within one year	$	32,756	$	32,779
	Maturing in one to three years	34,194		34,199
	Maturing in more than three years	—		—
		$	66,950	$	66,978

7_STOCK_BASED_COMPENSATION_Tab

7. STOCK- BASED COMPENSATION (Tables)	9 Months Ended
	Dec. 31, 2013
Stock- Based Compensation Tables	'
Summary of stock option activities	'
				Weighted
		Number of Shares		Average		Weighted
		Underlying		Remaining		Average
		Options		Contractual		Exercise			Intrinsic
		Outstanding		Life (Years)		Price			Value
	Balance at March 31, 2013	6,336,319				$	4.73
	Granted	678,483				6.42
	Exercised	(723,673	)			2.97			$	2,386,568
	Forfeited	(141,320	)			6.01
	Balance at December 31, 2013	6,149,809				$	5.09
	Options vested and exercisable	3,748,121		4.78		$	4.56		$	7,989,938
	Options vested and expected to vest	6,083,320		6.12		$	5.08		$	9,916,505
Schedule of options outstanding by exercise price	'
		Number of		Options Outstanding					Options Exercisable
		Shares		Weighted			Weighted Average				Weighted
		Underlying		Average			Remaining		Number		Average
		Options		Exercise			Contractual		Vested and		Exercise
	Exercise Price	Outstanding		Price			Life (Years)		Exercisable		Price
	$2.43 - 3.38	647,144		$	3.01		4.78		647,144		$	3.01
	$3.43 - 3.94	498,291		$	3.55		5.27		498,291		$	3.55
	$4.00	697,038		$	4		5.43		697,038		$	4
	$4.17 - 4.50	652,634		$	4.26		5.84		369,545		$	4.32
	$4.81 - 4.92	511,335		$	4.87		8.19		132,690		$	4.88
	$5.50	817,333		$	5.5		2.86		817,333		$	5.5
	$5.59 - 5.76	622,280		$	5.7		7.55		206,845		$	5.71
	$6.00 - 6.54	818,658		$	6.32		7.38		158,299		$	6.34
	$6.63 - 7.00	771,476		$	6.86		8.33		158,221		$	6.93
	$9.20	113,620		$	9.2		7.08		62,715		$	9.2
		6,149,809							3,748,121
Summary of stock-based compensation expense by line item	'
		Three Months Ended Dec. 31,						Nine Months Ended Dec. 31,
		2013			2012			2013			2012
		(In thousands)
	Cost of revenues	$	86		$	68		$	282		$	245
	Research and development	235			287			726			861
	Selling, general and administrative	195			210			636			582
	Total	$	516		$	565		$	1,644		$	1,688
Summary of valuation assumptions	'
		Three Months Ended Dec. 31,				Nine Months Ended Dec. 31,
		2013		2012		2013		2012
	Stock Option Plans:
	Risk-free interest rate	1.43%		0.69%		0.91 - 1.51%		0.67 - 0.79%
	Expected life (in years)	5		5		5		5
	Volatility	46.60%		50.20%		46.6 - 48.4%		50.2 - 52.9%
	Dividend yield	—%		—%		—%		—%
	Employee Stock Purchase Plan:
	Risk-free interest rate	0.07%		0.14%		0.07 - 0.09%		0.14 - 0.15%
	Expected life (in years)	0.5		0.5		0.5		0.5
	Volatility	32.80%		47.30%		30.4 - 32.8%		23.4 - 47.3%
	Dividend yield	—%		—%		—%		—%

8_SEGMENT_AND_GEOGRAPHIC_INFOR1

8. SEGMENT AND GEOGRAPHIC INFORMATION (Tables)	9 Months Ended
	Dec. 31, 2013
Segment Reporting	'
Net revenues by geographic area	'
		Three Months Ended Dec. 31,				Nine Months Ended Dec. 31,
		2013		2012		2013		2012
		(In thousands)
	United States	$	4,123	$	4,951	$	14,507	$	14,152
	China	3,465		2,746		9,736		11,054
	Malaysia	2,310		5,929		7,865		13,662
	Singapore	1,803		1,989		4,868		5,497
	Netherlands	768		575		4,180		1,580
	Rest of the world	1,309		1,324		4,576		4,362
		$	13,778	$	17,514	$	45,732	$	50,307

1_THE_COMPANY_AND_SUMMARY_OF_S2

1. THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Company And Summary Of Significant Accounting Policies Details Narrative	'	'	'	'
Provision for excess and obsolete inventories	$1,100,000	$253,000	$1,642,000	$544,000

2_NET_INCOME_LOSS_PER_COMMON_S2

2. NET INCOME (LOSS) PER COMMON SHARE (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Net Income (Loss) Per Common Share Details	'	'	'	'
Net income (loss)	($734)	$844	($789)	$2,896
Weighted average shares-Basic	27,667	26,963	27,495	27,152
Dilutive effect of employee stock options	'	1,024	'	805
Dilutive effect of employee stock purchase plan options	0	'	'	'
Weighted average shares-Dilutive	27,667	27,987	27,495	27,957
Net income (loss) common share - Basic	($0.03)	$0.03	($0.03)	$0.11
Net income (loss) common share - Diluted	($0.03)	$0.03	($0.03)	$0.10

2_NET_INCOME_LOSS_PER_COMMON_S3

2. NET INCOME (LOSS) PER COMMON SHARE (Details 1)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Net Income (Loss) Per Common Share Details 1	'	'	'	'
Shares underlying options	3,027	3,243	3,026	3,130

3_BALANCE_SHEET_DETAIL_Details

3. BALANCE SHEET DETAIL (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Inventories:	'	'
Work-in-progress	$2,674	$4,236
Finished goods	6,002	8,772
Inventory at distributors	545	801
Total Inventory	$9,221	$13,809

3_BALANCE_SHEET_DETAIL_Details1

3. BALANCE SHEET DETAIL (Details 1) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Accounts receivable, net:	'	'
Accounts receivable	$9,155	$10,357
Less: Allowances for sales returns, doubtful accounts and other	-101	-116
Total accounts receivable, net	$9,054	$10,241

3_BALANCE_SHEET_DETAIL_Details2

3. BALANCE SHEET DETAIL (Details 2) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Prepaid expenses and other current assets:	'	'
Prepaid tooling and masks	$580	$1,230
Prepaid income taxes	2,144	2,037
Other receivables	388	557
Other prepaid expenses	978	1,121
Total prepaid expenses and other current assets	$4,090	$4,945

3_BALANCE_SHEET_DETAIL_Details3

3. BALANCE SHEET DETAIL (Details 3) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
Property and equipment, net:	'	'	'	'	'
Computer and other equipment	$16,483,000	'	$16,483,000	'	$16,344,000
Software	4,779,000	'	4,779,000	'	4,690,000
Land	3,900,000	'	3,900,000	'	3,900,000
Building and building improvements	2,256,000	'	2,256,000	'	2,256,000
Furniture and fixtures	110,000	'	110,000	'	110,000
Leasehold improvements	792,000	'	792,000	'	767,000
Construction in progress	'	'	'	'	51,000
Property, Plant, and Equipment, Gross	28,320,000	'	28,320,000	'	28,118,000
Less: Accumulated depreciation and amortization	-18,695,000	'	-18,695,000	'	-17,344,000
Property, Plant, and Equipment, Net	9,625,000	'	9,625,000	'	10,774,000
Depreciation and amortization	$443,000	$531,000	$1,351,000	$1,712,000	'

3_BALANCE_SHEET_DETAIL_Details4

3. BALANCE SHEET DETAIL (Details 4) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
Other assets:	'	'	'	'	'
Non-current deferred income taxes	$1,696,000	'	$1,696,000	'	$1,272,000
Intangibles, net	609,000	'	609,000	'	744,000
Deposits	82,000	'	82,000	'	82,000
Total Other Assets	2,387,000	'	2,387,000	'	2,098,000
Amortization of intangible assets	$45,000	$45,000	$135,000	$135,000	'

3_BALANCE_SHEET_DETAIL_Details5

3. BALANCE SHEET DETAIL (Details 5) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Gross Carrying Amount	$1,390	'
Accumulated Amortization	-781	'
Net Carrying Amount	609	744
Product Designs	'	'
Gross Carrying Amount	590	'
Accumulated Amortization	-365	'
Net Carrying Amount	225	'
Patents	'	'
Gross Carrying Amount	720	'
Accumulated Amortization	-347	'
Net Carrying Amount	373	'
Software	'	'
Gross Carrying Amount	80	'
Accumulated Amortization	-69	'
Net Carrying Amount	$11	'

3_BALANCE_SHEET_DETAIL_Details6

3. BALANCE SHEET DETAIL (Details 6) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Accrued expenses and other liabilities:	'	'
Accrued compensation	$2,238	$2,181
Accrued professional fees	701	560
Accrued commissions	299	353
Other accrued expenses	722	884
Total Accrued Expenses and Other Liabilities	$3,960	$3,978

4_INCOME_TAXES_Details_Narrati

4. INCOME TAXES (Details Narrative) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
Income Taxes Details Narrative	'	'	'
Unrecognized tax benefits, Current	$0	'	$0
Unrecognized tax benefits, Long Term	2,163,000	'	2,803,000
Unrecognized tax benefits had been recorded as a reduction to net deferred tax assets	544,000	'	'
Unrecognized tax benefits	2,329,000	'	'
Reduction in uncertain tax benefits	775,000	'	'
Discrete benefit from tax provision associated with net result of settlement and associated tax reserves	'	168,000	'
Valuation allowance for California research and development tax credit carryforward	$371,000	'	'
Effective annual income tax rate	34.50%	26.10%	'

5_FINANCIAL_INSTRUMENTS_Detail

5. FINANCIAL INSTRUMENTS (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Assets:	'	'
Money market funds	$7,044	$10,445
Marketable securities	66,978	61,634
Total	74,022	72,079
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)	'	'
Assets:	'	'
Money market funds	7,044	10,445
Total	7,044	10,445
Significant Other Observable Inputs (Level 2)	'	'
Assets:	'	'
Marketable securities	66,978	61,634
Total	$66,978	$61,634

5_FINANCIAL_INSTRUMENTS_Detail1

5. FINANCIAL INSTRUMENTS (Details 1) (USD $)	9 Months Ended
	Dec. 31, 2013	Mar. 31, 2013
Fair Value	$66,978,000	'
Maximum maturity period of investment portfolio	'3 years	'
Deferred tax liability related to unrecognized gains and losses on short-term and long-term investments	7,000	'
Deferred tax liability related to unrecognized gains and losses on long-term investments	'	14,000
Short Term Investments	'	'
Available-for-sale securities, Cost	32,756,000	26,096,000
Available-for-sale securities, Gross Unrealized Gains	23,000	43,000
Fair Value	32,779,000	26,139,000
Short Term Investments | State and municipal bonds	'	'
Available-for-sale securities, Cost	7,688,000	10,564,000
Available-for-sale securities, Gross Unrealized Gains	1,000	17,000
Available-for-sale securities, Gross Unrealized Losses	0	'
Fair Value	7,689,000	10,581,000
Short Term Investments | Corporate Notes	'	'
Available-for-sale securities, Cost	3,018,000	6,052,000
Available-for-sale securities, Gross Unrealized Gains	7,000	14,000
Available-for-sale securities, Gross Unrealized Losses	0	'
Fair Value	3,025,000	6,066,000
Short Term Investments | Agency bonds	'	'
Available-for-sale securities, Cost	5,527,000	'
Available-for-sale securities, Gross Unrealized Gains	8,000	'
Available-for-sale securities, Gross Unrealized Losses	0	'
Fair Value	5,535,000	'
Short Term Investments | Certificate of deposits	'	'
Available-for-sale securities, Cost	14,999,000	9,480,000
Available-for-sale securities, Gross Unrealized Gains	5,000	12,000
Fair Value	15,004,000	9,492,000
Short Term Investments | Other	'	'
Available-for-sale securities, Cost	1,524,000	'
Available-for-sale securities, Gross Unrealized Gains	2,000	'
Available-for-sale securities, Gross Unrealized Losses	0	'
Fair Value	1,526,000	'
Long Term Investments	'	'
Available-for-sale securities, Cost	34,194,000	35,478,000
Available-for-sale securities, Gross Unrealized Gains	29,000	35,000
Available-for-sale securities, Gross Unrealized Losses	-24,000	-18,000
Fair Value	34,199,000	35,495,000
Long Term Investments | State and municipal bonds	'	'
Available-for-sale securities, Cost	9,048,000	11,992,000
Available-for-sale securities, Gross Unrealized Gains	2,000	3,000
Fair Value	9,050,000	11,995,000
Long Term Investments | Corporate Notes	'	'
Available-for-sale securities, Cost	7,408,000	8,436,000
Available-for-sale securities, Gross Unrealized Gains	27,000	14,000
Fair Value	7,435,000	8,450,000
Long Term Investments | Agency bonds	'	'
Available-for-sale securities, Cost	999,000	'
Available-for-sale securities, Gross Unrealized Losses	-2,000	'
Fair Value	997,000	'
Long Term Investments | Certificate of deposits	'	'
Available-for-sale securities, Cost	10,751,000	9,008,000
Available-for-sale securities, Gross Unrealized Gains	'	18,000
Available-for-sale securities, Gross Unrealized Losses	-21,000	'
Fair Value	10,730,000	9,026,000
Long Term Investments | Other	'	'
Available-for-sale securities, Cost	5,988,000	6,042,000
Available-for-sale securities, Gross Unrealized Losses	-1,000	-18,000
Fair Value	$5,987,000	$6,024,000

5_FINANCIAL_INSTRUMENTS_Detail2

5. FINANCIAL INSTRUMENTS (Details 2) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Financial Instruments Details 2	'
Maturing within one year, Cost	$32,756
Maturing in one to three years, Cost	34,194
Total, Cost	66,950
Maturing within one year, Fair Value	32,779
Maturing in one to three years, Fair Value	34,199
Fair Value	$66,978

6_COMMITMENTS_AND_CONTINGENCIE1

6. COMMITMENTS AND CONTINGENCIES (Details)	9 Months Ended
	Dec. 31, 2013
	item
Commitments and Contingencies Disclosure	'
Warranty period	'3 years
Number of patents infringed	3
Number of patents filed	5
Number of additional patents filed	1
Number of patents infringed by distributors and customers	3
Number of customers who infringed patents	11
Number of additional patents infringed	5
Number of patent claims transferred	2

7_STOCK_BASED_COMPENSATION_Det

7. STOCK- BASED COMPENSATION (Details) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Shares available for grant	'	'	'	'
Shares of common stock available for grant, Ending	5,671,955	'	5,671,955	'
Number of Options	'	'	'	'
Number of Underlying Options Outstanding, Beginning	'	'	6,336,319	'
Number of Underlying Options Granted	'	'	678,483	'
Number of Underlying Options Exercised	'	'	-723,673	'
Number of Underlying Options Forfeited	'	'	-141,320	'
Number of Options Underlying Outstanding, Ending	6,149,809	'	6,149,809	'
Options Vested and Exercisable	3,748,121	'	3,748,121	'
Options Vested and expected to vest	6,083,320	'	6,083,320	'
Weighted Average Exercise Price	'	'	'	'
Weighted Average Exercise Price Outstanding, Beginning	'	'	$4.73	'
Weighted Average Exercise Price Granted	'	'	$6.42	'
Weighted Average Exercise Price Exercised	'	'	$2.97	'
Weighted Average Exercise Price Forfeited	'	'	$6.01	'
Weighted Average Exercise Price Outstanding, Ending	$5.09	'	$5.09	'
Weighted Average Exercise Price Vested and Exercisable	$4.56	'	$4.56	'
Weighted Average Exercise Price vested and expected to vest	$5.08	'	$5.08	'
Weighted Average Remaining Contractual Life (in years)	'	'	'	'
Weighted Average Remaining Contractual Life (in years) Exercisable	'	'	'4 years 9 months 11 days	'
Weighted Average Remaining Contractual Life (in years) Vested and expected to vest	'	'	'6 years 1 month 13 days	'
Aggregate Intrinsic Value	'	'	'	'
Intrinsic Value of Exercised Options	'	'	$2,386,568	'
Aggregate Intrinsic Value Exercisable	7,989,938	'	7,989,938	'
Aggregate Intrinsic Value vested and expected to vest	$9,916,505	'	$9,916,505	'
Weighted average fair value per underlying share of options granted (in dollars per share)	$2.78	$2.43	$2.73	$2.12
Options outstanding by exercise price	'	'	'	'
Exercise Price (in dollars per share)	$5.09	'	$5.09	'
Number of Shares Underlying Options Outstanding (in shares)	6,149,809	'	6,149,809	'
Options Exercisable, Number Vested and Exercisable (in shares)	3,748,121	'	3,748,121	'
$2.43 - 3.38	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$2.43	'
Exercise Price, high end of range (in dollars per share)	'	'	$3.38	'
Number of Shares Underlying Options Outstanding (in shares)	647,144	'	647,144	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$3.01	'	$3.01	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'4 years 9 months 11 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	647,144	'	647,144	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$3.01	'	$3.01	'
$3.43 - 3.94	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$3.43	'
Exercise Price, high end of range (in dollars per share)	'	'	$3.94	'
Number of Shares Underlying Options Outstanding (in shares)	498,291	'	498,291	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$3.55	'	$3.55	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'5 years 3 months 7 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	498,291	'	498,291	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$3.55	'	$3.55	'
$4	'	'	'	'
Weighted Average Exercise Price	'	'	'	'
Weighted Average Exercise Price Outstanding, Ending	$4	'	$4	'
Options outstanding by exercise price	'	'	'	'
Exercise Price (in dollars per share)	$4	'	$4	'
Number of Shares Underlying Options Outstanding (in shares)	697,038	'	697,038	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$4	'	$4	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'5 years 5 months 5 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	697,038	'	697,038	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$4	'	$4	'
$4.17 - 4.50	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$4.17	'
Exercise Price, high end of range (in dollars per share)	'	'	$4.50	'
Number of Shares Underlying Options Outstanding (in shares)	652,634	'	652,634	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$4.26	'	$4.26	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'5 years 10 months 2 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	369,545	'	369,545	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$4.32	'	$4.32	'
$4.81 - 4.92	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$4.81	'
Exercise Price, high end of range (in dollars per share)	'	'	$4.92	'
Number of Shares Underlying Options Outstanding (in shares)	511,335	'	511,335	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$4.87	'	$4.87	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'8 years 2 months 8 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	132,690	'	132,690	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$4.88	'	$4.88	'
$5.50	'	'	'	'
Weighted Average Exercise Price	'	'	'	'
Weighted Average Exercise Price Outstanding, Ending	$5.50	'	$5.50	'
Options outstanding by exercise price	'	'	'	'
Exercise Price (in dollars per share)	$5.50	'	$5.50	'
Number of Shares Underlying Options Outstanding (in shares)	817,333	'	817,333	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$5.50	'	$5.50	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'2 years 10 months 10 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	817,333	'	817,333	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$5.50	'	$5.50	'
$5.59 - 5.76	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$5.59	'
Exercise Price, high end of range (in dollars per share)	'	'	$5.76	'
Number of Shares Underlying Options Outstanding (in shares)	622,280	'	622,280	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$5.70	'	$5.70	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'7 years 6 months 18 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	206,845	'	206,845	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$5.71	'	$5.71	'
$6.00 - 6.54	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$6	'
Exercise Price, high end of range (in dollars per share)	'	'	$6.54	'
Number of Shares Underlying Options Outstanding (in shares)	818,658	'	818,658	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$6.32	'	$6.32	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'7 years 4 months 17 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	158,299	'	158,299	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$6.34	'	$6.34	'
$6.63 - 7.00	'	'	'	'
Options outstanding by exercise price	'	'	'	'
Exercise Price, low end of range (in dollars per share)	'	'	$6.63	'
Exercise Price, high end of range (in dollars per share)	'	'	$7	'
Number of Shares Underlying Options Outstanding (in shares)	771,476	'	771,476	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$6.86	'	$6.86	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'8 years 3 months 29 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	158,221	'	158,221	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$6.93	'	$6.93	'
$9.20	'	'	'	'
Weighted Average Exercise Price	'	'	'	'
Weighted Average Exercise Price Outstanding, Ending	$9.20	'	$9.20	'
Options outstanding by exercise price	'	'	'	'
Exercise Price (in dollars per share)	$9.20	'	$9.20	'
Number of Shares Underlying Options Outstanding (in shares)	113,620	'	113,620	'
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$9.20	'	$9.20	'
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'	'	'7 years 29 days	'
Options Exercisable, Number Vested and Exercisable (in shares)	62,715	'	62,715	'
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$9.20	'	$9.20	'

7_STOCK_BASED_COMPENSATION_Det1

7. STOCK- BASED COMPENSATION (Details 1) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Stock-based compensation	$516,000	$565,000	$1,644,000	$1,688,000
Tax benefit recognized from allocation of share-based compensation expense	35,000	51,000	81,000	167,000
Windfall tax benefits realized from exercised stock options	'	'	280,000	20,000
Unrecognized compensation costs	4,000,000	'	4,000,000	'
Weighted average period of recognition of unrecognized compensation costs	'	'	'2 years 4 days	'
Cost of revenues	'	'	'	'
Stock-based compensation	86,000	68,000	282,000	245,000
Research and Development.	'	'	'	'
Stock-based compensation	235,000	287,000	726,000	861,000
Selling, general and administrative	'	'	'	'
Stock-based compensation	$195,000	$210,000	$636,000	$582,000

7_STOCK_BASED_COMPENSATION_Det2

7. STOCK- BASED COMPENSATION (Details 2)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Stock Options Plans	'	'	'	'
Risk-free interest rate	1.43%	0.69%	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	'	'	0.91%	0.67%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	'	'	1.51%	0.79%
Expected life (in years)	'5 years	'5 years	'5 years	'5 years
Volatility	46.60%	50.20%	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	'	'	46.60%	50.20%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	'	'	48.40%	52.90%
Dividend yield	0.00%	0.00%	0.00%	0.00%
Employee Stock Purchase Plan	'	'	'	'
Risk-free interest rate	0.07%	0.14%	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	'	'	0.07%	0.14%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	'	'	0.09%	0.15%
Expected life (in years)	'6 months	'6 months	'6 months	'6 months
Volatility	32.80%	47.30%	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	'	'	30.40%	23.40%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	'	'	32.80%	47.30%
Dividend yield	0.00%	0.00%	0.00%	0.00%

8_SEGMENT_AND_GEOGRAPHIC_INFOR2

8. SEGMENT AND GEOGRAPHIC INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
			item
Segment And Geographic Information Details	'	'	'	'
Number of reportable business segments	'	'	1	'
Statement	'	'	'	'
Net revenues	$13,778	$17,514	$45,732	$50,307
United States	'	'	'	'
Statement	'	'	'	'
Net revenues	4,123	4,951	14,507	14,152
China	'	'	'	'
Statement	'	'	'	'
Net revenues	3,465	2,746	9,736	11,054
Malaysia	'	'	'	'
Statement	'	'	'	'
Net revenues	2,310	5,929	7,865	13,662
Singapore	'	'	'	'
Statement	'	'	'	'
Net revenues	1,803	1,989	4,868	5,497
Netherlands	'	'	'	'
Statement	'	'	'	'
Net revenues	768	575	4,180	1,580
Rest of the World	'	'	'	'
Statement	'	'	'	'
Net revenues	$1,309	$1,324	$4,576	$4,362